Neurotrope, Inc. announced that Michael Ciraolo, J.D., Ph.D., is joining the company as general counsel and chief operating officer, effective April 1, 2019. Dr. Ciraolo joins the company from Ovid Therapeutics, where he served as senior vice president, chief intellectual property counsel from July 2015 to March 2019. Prior to that time, from February 2006 to July 2015, he served as an executive director at Forest Laboratories, where he held positions of increasing levels of responsibility, including Executive Director, Senior Patent Counsel. Dr. Ciraolo has been involved with the development of numerous pharmaceutical products and transactional matters, including mergers, acquisitions and licensing opportunities.